Burden of illness of HER2+in metastatic breast cancer (MBC) patients: A systematic literature review (SLR)

被引：0
|
作者：
Vondeling, G. [1 ]
Harding, T. [2 ]
Seddik, A. [3 ]
Bakker, K. [4 ]
Velikanova, R. [4 ]
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] AstraZeneca, Hlth Econ & Payer Evidence, Cambridge, England
[3] Dauchi Sankyo, Global Hlth Econ & Real World Evidence, Munich, Germany
[4] Asc Acad BV, Hlth Econ & Market Access, Groningen, Netherlands
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287P
引用
收藏
页码：S490 / S490
页数：1
相关论文
共 50 条
  • [41] The Economic Burden of Illness (BOI) of the Globally Spreading Chikungunya Virus (CHIKV): A Systematic and Targeted Literature Review (SLR AND TLR)
    Bakker, K.
    Hofstra, H.
    Gurgel, G.
    Dijkstra, A.
    Wolters, B.
    VALUE IN HEALTH, 2022, 25 (12) : S213 - S214
  • [42] Burden of illness in second-line colorectal cancer: A systematic literature review
    Priedane, Eugenia
    Xu, Yingxin
    Wilson, David
    Guillermo, Juan
    Mosqueda, Jasso
    Iqbal, Sheikh Usman
    Naoshy, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Safety and immunologic activity of anakinra in HER2-negative metastatic breast cancer (MBC).
    O'Shaughnessy, Joyce
    Young, Robyn R.
    Levin, Maren K.
    Baisch, Jeanine
    Timis, Roxana
    Muniz, Luz Stella
    Turner, Jacob
    Pascual, Virginia
    Palucka, Karolina
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Excellent Response to Oral Etoposide in HER2-Positive Metastatic Breast Cancer (MBC)
    Manikandan Dhanushkodi
    Priya Iyer
    Balasubramanian Ananthi
    Arvind Krishnamurthy
    K. M. Lakshmipathy
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [45] Excellent Response to Oral Etoposide in HER2-Positive Metastatic Breast Cancer (MBC)
    Dhanushkodi, Manikandan
    Iyer, Priya
    Ananthi, Balasubramanian
    Krishnamurthy, Arvind
    Lakshmipathy, K. M.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [46] Lapatinib with trastuzumab for heavily treated HER2-positive metastatic breast cancer (mBC).
    Sotelo, Miguel J.
    Manso, Luis
    Garcia Saenz, Jose Angel
    Ciruelos, Eva M.
    Moreno, Fernando
    Mendiola, Cesar
    Callata, Hector
    Ghanem, Ismael
    Cabezas, Santiago
    Gonzalez-Larriba, Jose-Luis
    Diaz Rubio, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Therapeutic options in HER2 positive metastatic breast cancer (MBC): An embarrassment of riches
    Efrat , Noa
    TUMOR BIOLOGY, 2012, 33 : 36 - 36
  • [48] Dravet syndrome: A systematic literature review of the illness burden
    Strzelczyk, Adam
    Lagae, Lieven
    Wilmshurst, Jo M.
    Brunklaus, Andreas
    Striano, Pasquale
    Rosenow, Felix
    Schubert-Bast, Susanne
    EPILEPSIA OPEN, 2023, 8 (04) : 1256 - 1270
  • [49] Jones fractures in patients with metastatic breast cancer (MBC)
    Van Poznak, C
    Boland, P
    Morris, C
    Dickler, M
    Hudis, C
    Healey, J
    BONE, 2006, 38 (03) : S85 - S85
  • [50] Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature
    Ge, Jennifer Y.
    Overmoyer, Beth
    CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 1071 - 1079
12345